Aranthan Jones II

Insider Reports History

Entity
Individual
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington Dc, DC
Signature
/s/ Aranthan S. Jones II
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aranthan Jones II:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Chief Corp. Affairs Officer Common Stock 82K $479K $5.84 Sep 15, 2021 Direct
Vanda Pharmaceuticals Inc. Chief Corp. Affairs Officer Employee Stock Option (Right to Buy) 47.2K Sep 15, 2021 Direct

Insider Reports Filed by Aranthan Jones II

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. Sep 15, 2021 5 -$136K 4 Sep 17, 2021 Chief Corp. Affairs Officer
VNDA Vanda Pharmaceuticals Inc. Jul 26, 2021 1 -$143K 4 Jul 27, 2021 Chief Corp. Affairs Officer